The Bard lawsuit is an individual federal case inside MDL No. 3081, while alternatives include waiting through bellwether trials or reporting to FDA without suing.
No single choice pays every claimant, because each MDL case stays separate and requires individual proof. A Bard PowerPort is an implanted port used largely for chemotherapy. Plaintiffs allege the catheter can fracture, migrate, cause infection, clots and embolism, and require removal or cardiac surgery.
Official resources:
- Read the original report from FDA — Use this primary source to review the complete report.
- Read the official notice from Aboutlawsuits — Use this primary source to verify the official announcement.
Table of Contents
- What is the Bard PowerPort MDL?
- What have the first bellwether trials decided?
- Is there a settlement or recall?
- How does filing compare with waiting?
- What can you do without filing suit?
What is the Bard PowerPort MDL?
More than 3,700 federal cases are centralized as MDL No. 3081 before Judge David G. Campbell in Arizona for coordinated discovery and bellwether trials, according to AboutLawsuits's September 2026 update in the third bellwether trial report.
Centralization avoids duplicate discovery while keeping each lawsuit individual. Unlike a class action with one binding resolution, an MDL preserves separate claims. The Texas Bar Journal explains that any MDL settlement requires individual consent and values vary by injury.
What have the first bellwether trials decided?
The first trial, Cook v. Becton Dickinson, ended in May 2026 with a defense verdict on warning and consumer-fraud claims, according to Doyle APC's September 2026 update. Jurors deadlocked on the central design-defect claims. The second trial produced the opposite signal.
In Divelbliss v. Becton Dickinson, an Arizona jury awarded $40 million in compensatory damages on Sept. 4, 2026 after finding design defect and failure to warn, but denied punitive damages, according to AboutLawsuits in the $40 million verdict report. One plaintiff win does not set another claimant's value.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Is there a settlement or recall?
No global Bard PowerPort settlement had been announced as of September-October 2026, according to Doyle APC and Drugwatch's October 2026 update. The $40 million award was an individual jury verdict for one plaintiff.
There is also no broad PowerPort recall for fracture or migration. Drugwatch's October 2026 update reports only a limited 2019-2020 FDA Class II component recall, terminated in 2022, despite 438 MAUDE reports from December 2025 to February 2026.
How does filing compare with waiting?
Filing places a claimant in the individual-proof track. Additional bellwether trials set for October 13 and December 2026 and February 2027 will further signal settlement posture, according to a September 11, 2026 Legal Bay announcement, but non-tried cases must still prove individual causation or await remand.
Waiting lets later claimants watch those signals before hiring counsel or accepting an offer. The tradeoff is delay, possible evidence loss, and continued medical risk without legal preservation.
What can you do without filing suit?
Patients and clinicians can voluntarily report fractures or malfunctions to FDA MedWatch online or at 1-800-332-1088, according to the FDA's adverse-event reporting page in the FDA reporting guide. Reporting creates a safety record without starting litigation. Practical options break down this way:.
- File an individual MDL case if removal, embolism, cardiac surgery, or major clot and infection caused clear costs.
- Monitor Oct. 2026 through Feb. 2027 bellwethers if uncertain about causation or settlement value.
- Submit a MedWatch report promptly after any fracture, migration, malfunction, or hospitalization, and keep explant records.
- Seek medical care first for chest pain, irregular heartbeat, swelling, fever, or infusion failure.
You Might Also Like
- Novo Nordisk Lawsuit vs Alternatives: Legal Paths Compared
- Hip Replacement Lawsuit vs Alternatives: Legal Paths Compared
- Camp Lejeune Settlement Offers vs Alternatives: Legal Paths Compared